These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34311770)

  • 41. Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study.
    Nikiphorou E; de Lusignan S; Mallen CD; Khavandi K; Bedarida G; Buckley CD; Galloway J; Raza K
    Heart; 2020 Oct; 106(20):1566-1572. PubMed ID: 32209618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial.
    Geller BJ; Mega JL; Morrow DA; Guo J; Hoffman EB; Gibson CM; Ruff CT
    J Thromb Thrombolysis; 2014 Apr; 37(3):310-6. PubMed ID: 23860881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant levels of natural IgM antibodies in osteoarthritis and rheumatoid arthritis patients in comparison to healthy controls.
    Nguyen TG; McKelvey KJ; March LM; Hunter DJ; Xue M; Jackson CJ; Morris JM
    Immunol Lett; 2016 Feb; 170():27-36. PubMed ID: 26744098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL.
    Fiskesund R; Su J; Bulatovic I; Vikström M; de Faire U; Frostegård J
    Results Immunol; 2012; 2():13-8. PubMed ID: 24371562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.
    Nielen MM; van Schaardenburg D; Reesink HW; van de Stadt RJ; van der Horst-Bruinsma IE; de Koning MH; Habibuw MR; Vandenbroucke JP; Dijkmans BA
    Arthritis Rheum; 2004 Feb; 50(2):380-6. PubMed ID: 14872479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S; Misra R; Aggarwal A
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18 months.
    Udachkina HV; Novikova DS; Popkova TV; Kirillova IG; Markelova EI
    Rheumatol Int; 2018 Jul; 38(7):1217-1224. PubMed ID: 29748857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60-Year-Olds.
    Thiagarajan D; Frostegård AG; Singh S; Rahman M; Liu A; Vikström M; Leander K; Gigante B; Hellenius ML; Zhang B; Zubarev RA; de Faire U; Lundström SL; Frostegård J
    J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27998914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic Variants of the NLRP3 Inflammasome Are Associated with Stroke in Patients with Rheumatoid Arthritis.
    Kastbom A; Ärlestig L; Rantapää-Dahlqvist S
    J Rheumatol; 2015 Oct; 42(10):1740-5. PubMed ID: 26178285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
    Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
    Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
    Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
    Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
    Front Immunol; 2018; 9():2388. PubMed ID: 30420853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
    Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
    Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus.
    Grönwall C; Reynolds H; Kim JK; Buyon J; Goldberg JD; Clancy RM; Silverman GJ
    Clin Immunol; 2014 Jul; 153(1):1-7. PubMed ID: 24704464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden.
    Fiskesund R; Stegmayr B; Hallmans G; Vikström M; Weinehall L; de Faire U; Frostegård J
    Stroke; 2010 Apr; 41(4):607-12. PubMed ID: 20150554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.
    Kaushik P; Solomon DH; Greenberg JD; Anderson JT; Reed G; Pala O; Sumbul-Yuksel B; Kadam P; Kremer JM;
    Clin Rheumatol; 2015 Oct; 34(10):1697-704. PubMed ID: 26242470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study.
    So H; Lam TO; Meng H; Lam SHM; Tam LS
    Ann Rheum Dis; 2023 Nov; 82(11):1387-1393. PubMed ID: 37487608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality.
    Samal SK; Qureshi AR; Rahman M; Stenvinkel P; Frostegård J
    Clin Exp Immunol; 2020 Jul; 201(1):94-104. PubMed ID: 32297318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.
    Grönlund H; Hallmans G; Jansson JH; Boman K; Wikström M; de Faire U; Frostegård J
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):382-6. PubMed ID: 19369878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural antibodies against phosphorylcholine as potential protective factors in SLE.
    Su J; Hua X; Concha H; Svenungsson E; Cederholm A; Frostegård J
    Rheumatology (Oxford); 2008 Aug; 47(8):1144-50. PubMed ID: 18522961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.